The Patent Finder

Northfield Laboratories, Inc.

Also on record
Records under this name other than patents Northfield Laboratories, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Northfield Laboratories, Inc.

PatentTitleStatus Expires Confidence
US 7,202,341Stabilized hemoglobin solutions
Formerly held
Lapsed on the fee record
Ended Apr 10, 2019 · From the USPTO record
Lapsed on the fee recordEnded Apr 10, 2019From the USPTO record
US 6,133,425Acellular red blood cell substitute
Formerly held
Term ended
Term ended Oct 17, 2017 · From the USPTO record
Term endedTerm ended Oct 17, 2017From the USPTO record
US 7,521,417Method and apparatus for preparing an acellular red blood cell substitute
Formerly held
Term ended
Ended no later than Mar 27, 2017 · From the USPTO record
Term endedEnded no later than Mar 27, 2017From the USPTO record
US 7,435,795Stabilized hemoglobin solutions
Formerly held
Lapsed on the fee record
Ended Oct 14, 2016 · From the USPTO record
Lapsed on the fee recordEnded Oct 14, 2016From the USPTO record
US 7,411,044Polymerized hemoglobin solutions having reduced amounts of tetramer and method for preparing
Formerly held
Lapsed on the fee record
Ended Aug 12, 2016 · From the USPTO record
Lapsed on the fee recordEnded Aug 12, 2016From the USPTO record
US 7,291,592Method for treating patients with massive blood loss
Formerly held
Lapsed on the fee record
Ended Nov 6, 2015 · From the USPTO record
Lapsed on the fee recordEnded Nov 6, 2015From the USPTO record
US 6,498,141Method and apparatus for preparing an acellular red blood cell substitute
Formerly held
Lapsed on the fee record
Ended Dec 24, 2014 · From the USPTO record
Lapsed on the fee recordEnded Dec 24, 2014From the USPTO record
US 6,323,320Acellular red blood cell substitute
Formerly held
Lapsed on the fee record
Ended Nov 27, 2013 · From the USPTO record
Lapsed on the fee recordEnded Nov 27, 2013From the USPTO record
US 7,135,553Polymerized hemoglobin solutions having reduced amounts of tetramer and method for preparing
Formerly held
Lapsed on the fee record
Ended Nov 14, 2010 · From the USPTO record
Lapsed on the fee recordEnded Nov 14, 2010From the USPTO record
US 6,914,127Acellular red blood cell substitute
Formerly held
Term ended
Term ended Jul 2, 2007 · From the USPTO record
Term endedTerm ended Jul 2, 2007From the USPTO record
10 of 18 patents shown.
Pro members see all 18.
Pro members: see all 18 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited